Insider Transactions in Q3 2021 at Regenxbio Inc. (RGNX)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2021
|
Kenneth T. Mills |
SELL
Open market or private sale
|
Direct |
1,500
-0.53%
|
$63,000
$42.19 P/Share
|
|
Sep 27
2021
|
Kenneth T. Mills |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+0.53%
|
$4,500
$3.76 P/Share
|
|
Sep 17
2021
|
Allan M. Fox |
SELL
Open market or private sale
|
Indirect |
48,233
-3.41%
|
$2,170,485
$45.04 P/Share
|
|
Sep 14
2021
|
Kenneth T. Mills |
SELL
Open market or private sale
|
Direct |
35,000
-11.08%
|
$1,575,000
$45.11 P/Share
|
|
Sep 14
2021
|
Kenneth T. Mills |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+5.06%
|
$70,000
$2.31 P/Share
|
|
Sep 13
2021
|
Kenneth T. Mills |
SELL
Open market or private sale
|
Direct |
3,000
-1.06%
|
$120,000
$40.02 P/Share
|
|
Sep 13
2021
|
Kenneth T. Mills |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+1.05%
|
$9,000
$3.76 P/Share
|
|
Jul 27
2021
|
Vittal Vasista Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.48%
|
$0
$0.85 P/Share
|